179 related articles for article (PubMed ID: 33833836)
1. Recurrent hepatogastric fistula during lenvatinib therapy for advanced hepatocellular carcinoma managed by over-the-scope clip closure: a case report.
Miwa T; Kochi T; Watanabe K; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
J Rural Med; 2021 Apr; 16(2):102-110. PubMed ID: 33833836
[No Abstract] [Full Text] [Related]
2. Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Grover I; Ahmad N; Googe AB
Case Rep Gastroenterol; 2014 Sep; 8(3):286-90. PubMed ID: 25408632
[TBL] [Abstract][Full Text] [Related]
3. Delayed spontaneous hepatogastric fistula formation following transcatheter arterial embolisation and radiotherapy for hepatocellular carcinoma.
Wang CY; Leung SW; Wang JH; Yu PC; Wang CC
Br J Radiol; 2009 Jun; 82(978):e105-7. PubMed ID: 19451307
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinoma.
Terashima T; Yamashita T; Takata N; Toyama T; Shimakami T; Takatori H; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Mizukoshi E; Honda M; Kaneko S
Hepatol Res; 2020 Jul; 50(7):871-884. PubMed ID: 32307874
[TBL] [Abstract][Full Text] [Related]
5. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report.
Yokoo H; Takahashi H; Hagiwara M; Iwata H; Imai K; Saito Y; Matsuno N; Furukawa H
World J Hepatol; 2020 Dec; 12(12):1349-1357. PubMed ID: 33442460
[TBL] [Abstract][Full Text] [Related]
6. Multimodal treatment involving molecular targeted agents and on-demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report and review of the literature.
Oura K; Takuma K; Nakahara M; Tadokoro T; Fujita K; Mimura S; Tani J; Morishita A; Kobara H; Masaki T
Mol Clin Oncol; 2021 Aug; 15(2):154. PubMed ID: 34178325
[TBL] [Abstract][Full Text] [Related]
7. Overview of lenvatinib as a targeted therapy for advanced hepatocellular carcinoma.
Rehman O; Jaferi U; Padda I; Khehra N; Atwal H; Mossabeh D; Bhangu R
Clin Exp Hepatol; 2021 Sep; 7(3):249-257. PubMed ID: 34712825
[TBL] [Abstract][Full Text] [Related]
8. Cotreatment with lenvatinib and warfarin potassium caused prothrombin time prolongation.
Sasaki Y; Sakamori R; Yamada R; Shigekawa M; Tahata Y; Makino Y; Nakabori T; Kodama T; Hikita H; Tatsumi T; Takehara T
Hepatol Res; 2019 Nov; 49(11):1357-1361. PubMed ID: 31119866
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases.
Morsica G; Bertoni C; Hasson H; Messina E; Uberti Foppa C
Front Oncol; 2023; 13():1242741. PubMed ID: 38115904
[TBL] [Abstract][Full Text] [Related]
10. Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment.
Chan KM; Lai Y; Hung HC; Lee JC; Cheng CH; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Wang CT; Chai PM; Lien HY; Lee WC
J Hepatocell Carcinoma; 2023; 10():281-290. PubMed ID: 36845025
[TBL] [Abstract][Full Text] [Related]
11. Lenvatinib-induced acute acalculous cholecystitis in a patient with hepatocellular carcinoma.
Ishigaki K; Hamada T; Nakai Y; Ishigaki Y; Oyama H; Kanai S; Suzuki T; Nakamura T; Sato T; Hakuta R; Saito K; Saito T; Takahara N; Mizuno S; Kogure H; Tateishi R; Tada M; Koike K
Clin J Gastroenterol; 2020 Aug; 13(4):568-571. PubMed ID: 32242306
[TBL] [Abstract][Full Text] [Related]
12. Over-the-Scope Clip Closure of Persistent Gastrocutaneous Fistula After Percutaneous Endoscopic Gastrostomy Tube Removal: A Report of Two Cases.
Masaki S; Yamada K
Cureus; 2021 Feb; 13(2):e13206. PubMed ID: 33728166
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician's Choice in a New Therapeutic Scenario.
Dipasquale A; Marinello A; Santoro A
J Hepatocell Carcinoma; 2021; 8():241-251. PubMed ID: 33884259
[TBL] [Abstract][Full Text] [Related]
14. Two hepatectomy cases for initially unresectable hepatocellular carcinoma after achieving a radiological complete response to sequential therapy with lenvatinib and transcatheter arterial chemoembolization.
Endo K; Kuroda H; Abe T; Sato H; Kooka Y; Oikawa T; Sato A; Nishiya M; Sugai T; Takikawa Y
Hepatol Res; 2021 Oct; 51(10):1082-1086. PubMed ID: 33982336
[TBL] [Abstract][Full Text] [Related]
15. Lenvatinib-induced tumor lysis syndrome in a patient with advanced hepatocellular carcinoma: a case report.
Shimizu Y; Sunagozaka H; Yamagata K; Hirai H; Miura M; Yonemoto Y; Naito Y; Hasatani K; Yoshikawa J; Aoyagi H; Kaneko S
Clin J Gastroenterol; 2021 Apr; 14(2):645-649. PubMed ID: 33389590
[TBL] [Abstract][Full Text] [Related]
16. Downstaging of Recurrent Advanced Hepatocellular Carcinoma After Lenvatinib Treatment: Opportunities or Pitfalls? A Case Report.
Liu Z; Fu Z; Li G; Lin D
Onco Targets Ther; 2020; 13():10267-10273. PubMed ID: 33116607
[TBL] [Abstract][Full Text] [Related]
17. Lenvatinib mesylate to treat hepatocellular carcinoma.
Ielasi L; Tovoli F; Piscaglia F
Drugs Today (Barc); 2019 May; 55(5):305-313. PubMed ID: 31131841
[TBL] [Abstract][Full Text] [Related]
18. Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma.
Chen K; Luo CP; Ge DX; Wang KL; Luo Q; Li YZ; You XM; Xiang BD; Li LQ; Ma L; Zhong JH
Front Oncol; 2022; 12():946693. PubMed ID: 36276151
[TBL] [Abstract][Full Text] [Related]
19. Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment.
Lin PT; Teng W; Jeng WJ; Lin CC; Lin CY; Lin SM; Sheen IS
J Formos Med Assoc; 2024 Feb; ():. PubMed ID: 38310071
[TBL] [Abstract][Full Text] [Related]
20. Long-term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion.
Takeda H; Nishijima N; Nasu A; Komekado H; Kita R; Kimura T; Kudo M; Osaki Y
Hepatol Res; 2019 May; 49(5):594-599. PubMed ID: 30499247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
